Literature DB >> 10405191

Bacterial meningitis in the newborn: a prospective study of mortality and morbidity.

D Harvey1, D E Holt, H Bedford.   

Abstract

Neonatal bacterial meningitis is a serious disease around the world, with the incidence changing little in the past 30 years. Group B streptococci, Escherichia coli, and Klebsiella pneumoniae are common causative organisms and lumbar puncture remains the definitive method of diagnosis. The mortality rate has declined in industrialized countries over the years, from almost 50% in the 1970s to less than 10% in 1997. However, neurological sequelae are still frequently observed despite major changes in treatment. Preliminary analysis of our own data from a prospective study of cases in the United Kingdom suggests that treatment with third generation cephalosporins is related to a decrease in mortality but not morbidity.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10405191     DOI: 10.1016/s0146-0005(99)80066-4

Source DB:  PubMed          Journal:  Semin Perinatol        ISSN: 0146-0005            Impact factor:   3.300


  27 in total

1.  Long term outcome of neonatal meningitis.

Authors:  J P Stevens; M Eames; A Kent; S Halket; D Holt; D Harvey
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2003-05       Impact factor: 5.747

2.  Oxidative stress, cytokine/chemokine and disruption of blood-brain barrier in neonate rats after meningitis by Streptococcus agalactiae.

Authors:  Tatiana Barichello; Joelson C Lemos; Jaqueline S Generoso; Andreza L Cipriano; Graziele L Milioli; Danielle M Marcelino; Francieli Vuolo; Fabricia Petronilho; Felipe Dal-Pizzol; Márcia Carvalho Vilela; Antonio Lucio Teixeira
Journal:  Neurochem Res       Date:  2011-06-03       Impact factor: 3.996

3.  Neonatal meningitis in England and Wales: 10 years on.

Authors:  D E Holt; S Halket; J de Louvois; D Harvey
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2001-03       Impact factor: 5.747

4.  Neonatal meningitis in England and Wales: sequelae at 5 years of age.

Authors:  John de Louvois; Susan Halket; David Harvey
Journal:  Eur J Pediatr       Date:  2005-09-01       Impact factor: 3.183

5.  Administration of capsule-selective endosialidase E minimizes upregulation of organ gene expression induced by experimental systemic infection with Escherichia coli K1.

Authors:  Andrea Zelmer; Melissa J Martin; Ozan Gundogdu; George Birchenough; Rebecca Lever; Brendan W Wren; J Paul Luzio; Peter W Taylor
Journal:  Microbiology (Reading)       Date:  2010-04-15       Impact factor: 2.777

6.  Altered innate defenses in the neonatal gastrointestinal tract in response to colonization by neuropathogenic Escherichia coli.

Authors:  George M H Birchenough; Malin E V Johansson; Richard A Stabler; Fatma Dalgakiran; Gunnar C Hansson; Brendan W Wren; J Paul Luzio; Peter W Taylor
Journal:  Infect Immun       Date:  2013-06-24       Impact factor: 3.441

7.  Functional and structural characterization of polysaccharide co-polymerase proteins required for polymer export in ATP-binding cassette transporter-dependent capsule biosynthesis pathways.

Authors:  Kane Larue; Robert C Ford; Lisa M Willis; Chris Whitfield
Journal:  J Biol Chem       Date:  2011-03-18       Impact factor: 5.157

8.  Use of diagnostic microarrays for determination of virulence gene patterns of Escherichia coli K1, a major cause of neonatal meningitis.

Authors:  Bozena Korczak; Joachim Frey; Jacques Schrenzel; Gerd Pluschke; Riccardo Pfister; Ralf Ehricht; Peter Kuhnert
Journal:  J Clin Microbiol       Date:  2005-03       Impact factor: 5.948

9.  Differential expression of the polysialyl capsule during blood-to-brain transit of neuropathogenic Escherichia coli K1.

Authors:  Andrea Zelmer; Mark Bowen; Anne Jokilammi; Jukka Finne; J Paul Luzio; Peter W Taylor
Journal:  Microbiology       Date:  2008-08       Impact factor: 2.777

10.  Pancytopenia due to linezolid treatment.

Authors:  Emine Parlak; Hüseyin Tan
Journal:  Turk Pediatri Ars       Date:  2015-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.